MASS
908 Devices Inc
$
7.050
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
7.190
Open
6.540
VWAP
6.81
Vol
390.35K
Mkt Cap
177.60M
Low
6.480
Amount
2.66M
EV/EBITDA(TTM)
--
Total Shares
34.49M
EV
139.26M
EV/OCF(TTM)
--
P/S(TTM)
3.99
908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
12.17M
-13.38%
-0.145
-53.45%
14.15M
-15.62%
-0.100
-67.27%
16.25M
-13.67%
-0.045
-83.95%
Estimates Revision
The market is revising Downward the revenue expectations for 908 Devices Inc. (MASS) for FY2025, with the revenue forecasts being adjusted by -1.36% over the past three months. During the same period, the stock price has changed by 51.61%.
Revenue Estimates for FY2025
Revise Downward
-1.36%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-15%
In Past 3 Month
Stock Price
Go Up
+51.61%
In Past 3 Month
4 Analyst Rating
-14.89% Downside
Wall Street analysts forecast MASS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASS is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
-14.89% Downside
Current: 7.050
Low
6.00
Averages
6.00
High
6.00
-14.89% Downside
Current: 7.050
Low
6.00
Averages
6.00
High
6.00
Leerink
Puneet Souda
Market Perform -> Outperform
upgrade
$12
2025-08-05
Reason
Leerink
Puneet Souda
Price Target
$12
2025-08-05
upgrade
Market Perform -> Outperform
Reason
Leerink analyst Puneet Souda upgraded 908 Devices to Outperform from Market Perform with a $12 price target.
Leerink
analyst
Market Perform
to
Outperform
upgrade
$7 -> $12
2025-08-05
Reason
Leerink
analyst
Price Target
$7 -> $12
2025-08-05
upgrade
Market Perform
to
Outperform
Reason
As previously reported, Leerink upgraded 908 Devices to Outperform from Market Perform with a price target of $12, up from $7. After the recent life science divestiture, 908 has "turned into a forensics and threat detection pure-play," says the analyst, who notes that the One Big Beautiful Act releases funds for enforcement, security, drug and broader threat detection. 908 is guiding to 15% pro-forma growth for the year, but expecting an acceleration in 2026, notes the analyst, who sees upside to the company's 20%-plus growth expectation for 2026.
Stephens & Co.
Jacob Johnson
Buy
Reiterates
$6
2025-01-15
Reason
Stephens & Co.
Jacob Johnson
Price Target
$6
2025-01-15
Reiterates
Buy
Reason
Leerink Partners
Puneet Souda
Buy
to
Hold
Downgrades
$12 → $4
2024-11-13
Reason
Leerink Partners
Puneet Souda
Price Target
$12 → $4
2024-11-13
Downgrades
Buy
to
Hold
Reason
Leerink downgraded 908 Devices to Market Perform from Outperform with a price target of $4, down from $12. Though the firm still sees promise in 908 Devices' differentiated process analytical technology portfolio and a technically strong management team, Leerink believes the well-known market headwinds in biopharma/life sciences are now made worse with an uncertain outlook in the forensics end-market. The firm expects 2025 estimates to step down further on a longer-than-expected recovery and federal budget delays/uncertainty impacting the forensics business. Historically the handheld business has served as a bridge through these headwinds, but the Q3 miss and significant guide-down leave Leerink more uncertain.
Stifel
Daniel Arias
Strong Buy
Maintains
$17 → $6
2024-11-13
Reason
Stifel
Daniel Arias
Price Target
$17 → $6
2024-11-13
Maintains
Strong Buy
Reason
Stifel analyst Daniel Arias lowered the firm's price target on 908 Devices to $6 from $17 and keeps a Buy rating on the shares after a "difficult" Q3 that included "a sharp guidance cut that raises questions about the growth trajectory in both 2024 and 2025." The Q3 report "exposed the issues with being heavily dependent" on government funding cycles at a time when instrument demand on the other side of the house remains weak for the company, the analyst added.
See All Ratings
Valuation Metrics
The current forward P/E ratio for 908 Devices Inc (MASS.O) is -19.94, compared to its 5-year average forward P/E of -21.44. For a more detailed relative valuation and DCF analysis to assess 908 Devices Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-21.44
Current PE
-19.94
Overvalued PE
4.11
Undervalued PE
-46.98
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-21.86
Current EV/EBITDA
-17.95
Overvalued EV/EBITDA
9.58
Undervalued EV/EBITDA
-53.31
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
10.05
Current PS
4.41
Overvalued PS
20.21
Undervalued PS
-0.10
Financials
Annual
Quarterly
FY2025Q1
YoY :
+58.68%
11.78M
Total Revenue
FY2025Q1
YoY :
+12.04%
-8.53M
Operating Profit
FY2025Q1
YoY :
+66.87%
-9.84M
Net Income after Tax
FY2025Q1
YoY :
-472.73%
1.23
EPS - Diluted
FY2025Q1
YoY :
+47.93%
-15.18M
Free Cash Flow
FY2025Q1
YoY :
-10.16%
47.05
Gross Profit Margin - %
FY2025Q1
YoY :
+5.16%
-83.53
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
233.9K
USD
4
3-6
Months
0.0
USD
0
6-9
Months
101.8K
USD
4
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
3
174.2K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 155.47% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
233.9K
USD
4
3-6
Months
0.0
USD
0
6-9
Months
101.8K
USD
4
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
3
174.2K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MASS News & Events
Events Timeline
2025-08-05 (ET)
2025-08-05
07:14:39
908 Devices reports Q2 EPS (37c), consensus (14c)
2025-05-13 (ET)
2025-05-13
07:13:38
908 Devices backs FY25 revenue view $53M-$54M, consensus $55.18M
2025-05-13
07:12:03
908 Devices reports Q1 continuing operations EPS (28c), consensus (27c)
Sign Up For More Events
Sign Up For More Events
News
9.5
08-06NASDAQ.COM908 Devices (MASS) Q2 Revenue Jumps 14%
4.0
08-05BenzingaLeerink Partners Upgrades 908 Devices to Outperform, Announces $12 Price Target
9.5
08-05Newsfilter908 Devices Inc. (MASS) Q2 2025 Earnings Call Transcript
Sign Up For More News
People Also Watch
PFX
PhenixFIN Corp
49.490
USD
-0.98%
STKS
One Group Hospitality Inc
2.750
USD
+0.73%
SILC
Silicom Ltd
16.221
USD
+2.34%
BSBK
Bogota Financial Corp
8.680
USD
+1.52%
CURR
CURRENC Group Inc
1.380
USD
+2.99%
PRPL
Purple Innovation Inc
1.050
USD
+24.40%
MAXN
Maxeon Solar Technologies Ltd
3.790
USD
+4.12%
FONR
Fonar Corp
15.240
USD
+0.86%
FNWB
First Northwest Bancorp
7.910
USD
-0.63%
CPHC
Canterbury Park Holding Corp
17.950
USD
+4.06%
FAQ
What is 908 Devices Inc (MASS) stock price today?
The current price of MASS is 7.05 USD — it has increased 8.96 % in the last trading day.
What is 908 Devices Inc (MASS)'s business?
What is the price predicton of MASS Stock?
What is 908 Devices Inc (MASS)'s revenue for the last quarter?
What is 908 Devices Inc (MASS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for 908 Devices Inc (MASS)'s fundamentals?
How many employees does 908 Devices Inc (MASS). have?